Discuss the Pathogenesis, Presentation and Management of HHS

α
Ismat Abdelrhman Alborhan Mohammed
Ismat Abdelrhman Alborhan Mohammed
α Cardiff University Cardiff University

Send Message

To: Author

Discuss the Pathogenesis, Presentation and Management of HHS

Article Fingerprint

ReserarchID

2S016

Discuss the Pathogenesis, Presentation and Management of HHS Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

Introduction-Hyperosmolar hyperglycaemic state (HHS) classically happens in type 2 diabetes formerly recognised as hyperosmolar non-ketotic (HONK) state. The level of blood glucose can be greater than that is DKA (>50 mmol/litre) however there is no ketone in urine. It is accompanying with severe dehydration and patients necessitate importunate, directed fluid resuscitation, correction of electrolyte disturbances and insulin. The characteristic features of HHS a syndrome are severe hyperglycaemia, hyper osmolality and excessive water loss in the non-appearance of ketoacidosis. Occurrence of HHS among diabetic patients is approximately less than 1%. Higher percentage of cases occur in elder type 2 diabetic patients still, young adult and children are also prone to develop HHS. The mortality rate approximately 20% which is around 10 times DKA mortality rate. The dehydration severity, existence of comorbidities and old age determined the prognosis of HHS. The management of HHS is focussed on correction of volume deficit, hyper osmolality, hyperglycaemia, and electrolyte abnormalities in addition to treating the underlying causes which trigger the metabolic decompensation. Although regime of intravenous low dose insulin meant for mange DKA seem to be effectual, the better therapy approaches for the treatment of HHS have not established by any prospective randomized studies.

References

35 Cites in Article
  1. C Hoy,C Beecroft (2016). The patient with endocrine disease.
  2. H Fishbein,P Palumbo (1995). Acute metabolic complications in diabetes.
  3. Arlan Rosenbloom (2010). Hyperglycemic Hyperosmolar State: An Emerging Pediatric Problem.
  4. H Milionis,M Elisaf (2005). Therapeutic management of hyperglycaemic hyperosmolar syndrome.
  5. Gian Fadini,Saula De Kreutzenberg,Mauro Rigato,Stefano Brocco,Maria Marchesan,Antonio Tiengo,Angelo Avogaro (2011). Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center.
  6. Abbas Kitabchi,Guillermo Umpierrez,John Miles,Joseph Fisher (2009). Hyperglycemic Crises in Adult Patients With Diabetes.
  7. G Umpierrez,J Kelly,J Navarrete,M Casals,A Kitabchi (1997). Hyperglycemic crises in urban blacks.
  8. Francisco Pasquel,Guillermo Umpierrez (2014). Hyperosmolar Hyperglycemic State: A Historic Review of the Clinical Presentation, Diagnosis, and Treatment.
  9. Michael Macaulay (1971). Hyperosmolar non-ketotic diabetes.
  10. L Luzi,E Barrett,L Groop,E Ferrannini,R Defronzo (1988). Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis.
  11. M Chupin,B Charbonnel,F Chupin (1981). C-peptide blood levels in keto-acidosis and in hyperosmolar non-ketotic diabetic coma.
  12. Justin Rains,Sushil Jain (2011). Oxidative stress, insulin signaling, and diabetes.
  13. Tom Wachtel,Linda Tetu-Mouradjian,Dona Goldman,Susan Ellis,Patricia O’sullivan (1991). Hyperosmolarity and acidosis in diabetes mellitus.
  14. Guillermo Umpierrez,Mary Murphy,Abbas Kitabchi (2002). Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome.
  15. Abbas Kitabchi,Ebenezer Nyenwe (2006). Hyperglycemic Crises in Diabetes Mellitus: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.
  16. Phil Zeitler,Andrea Haqq,Arlan Rosenbloom,Nicole Glaser (2011). Hyperglycemic Hyperosmolar Syndrome in Children: Pathophysiological Considerations and Suggested Guidelines for Treatment.
  17. F Coller,W Maddock (1935). A study of dehydration in adults.
  18. E Bartoli,L Bergamaco,L Castello,P Sainaghi (2009). Methods for the quantitative assessment of electrolyte disturbances in hyperglycaemia.
  19. (2001). American Diabetes Association: Hyperglycemic crises in patients with diabetes mellitus (Position Statement).
  20. E Ennis,Ejvb Stahl,R Kreisburg (1994). Hyperosmolar hyperglycemic nonketotic syndrome (HHNS).
  21. P Perel,J Roberts (2011). Colloids vs crystalloids for fluid resuscitation in critically ill patients.
  22. D Van Zyl,P Rheeder,E Delport (2012). Fluid management in diabetic-acidosis--Ringer's lactate versus normal saline: a randomized controlled trial.
  23. Junaid Birmingham (2002). To National Patient Safety Agency or not to National Patient Safety Agency: an audit on the current trends in paediatric intravenous fluid prescribing for surgical patients.
  24. A Kitabchi,G Umpierrez,M Murphy,E Barrett,R Kreisberg,J Malone,B Wall (2001). Management of hyperglycemic crises in patients with diabetes.
  25. P English,G Williams (2004). Hyperglycaemic crises and lactic acidosis in diabetes mellitus.
  26. Phil Zeitler,Andrea Haqq,Arlan Rosenbloom,Nicole Glaser (2011). Hyperglycemic Hyperosmolar Syndrome in Children: Pathophysiological Considerations and Suggested Guidelines for Treatment.
  27. Lawrence Morris,Abbas Kitabchi (1980). Efficacy of Low-Dose Insulin Therapy for Severely Obtunded Patients in Diabetic Ketoacidosis.
  28. A Scott (2015). The management of the hyperosmolar hyperglycaemic state in adults with diabetes: a summary of a report from the Joint British Diabetes Societies for Inpatient Care.
  29. Juan Gutierrez,Rochelle Bagatell,Meredith Samson,Andreas Theodorou,Robert Berg (2003). Femoral central venous catheter-associated deep venous thrombosis in children with diabetic ketoacidosis.
  30. R Mannix,M Tan,R Wright,M Baskin (2006). Acute pediatricrhabdomyolysis: causes and rates of renal failure.
  31. Abby Hollander,Robert Olney,Piers Blackett,Bess Marshall (2003). Fatal Malignant Hyperthermia-Like Syndrome With Rhabdomyolysis Complicating the Presentation of Diabetes Mellitus in Adolescent Males.
  32. Brendan Kilbane,Sanjeev Mehta,Philippe Backeljauw,Thomas Shanley,Nancy Crimmins (2006). Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus.
  33. Alba Morales,Arlan Rosenbloom (2004). Death caused by hyperglycemic hyperosmolar state at the onset of type 2 diabetes.
  34. A Rosenbloom (2010). Hyperglycemic hyperosmolar state: an emerging pediatric problem.
  35. Francisco Pasquel,Guillermo Umpierrez (2014). Hyperosmolar Hyperglycemic State: A Historic Review of the Clinical Presentation, Diagnosis, and Treatment.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Ismat Abdelrhman Alborhan Mohammed. 2018. \u201cDiscuss the Pathogenesis, Presentation and Management of HHS\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 18 (GJMR Volume 18 Issue F1): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-F Classification: NLMC Code: QZ 40
Version of record

v1.2

Issue date

April 20, 2018

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 3165
Total Downloads: 1531
2026 Trends
Related Research

Published Article

Introduction-Hyperosmolar hyperglycaemic state (HHS) classically happens in type 2 diabetes formerly recognised as hyperosmolar non-ketotic (HONK) state. The level of blood glucose can be greater than that is DKA (>50 mmol/litre) however there is no ketone in urine. It is accompanying with severe dehydration and patients necessitate importunate, directed fluid resuscitation, correction of electrolyte disturbances and insulin. The characteristic features of HHS a syndrome are severe hyperglycaemia, hyper osmolality and excessive water loss in the non-appearance of ketoacidosis. Occurrence of HHS among diabetic patients is approximately less than 1%. Higher percentage of cases occur in elder type 2 diabetic patients still, young adult and children are also prone to develop HHS. The mortality rate approximately 20% which is around 10 times DKA mortality rate. The dehydration severity, existence of comorbidities and old age determined the prognosis of HHS. The management of HHS is focussed on correction of volume deficit, hyper osmolality, hyperglycaemia, and electrolyte abnormalities in addition to treating the underlying causes which trigger the metabolic decompensation. Although regime of intravenous low dose insulin meant for mange DKA seem to be effectual, the better therapy approaches for the treatment of HHS have not established by any prospective randomized studies.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Discuss the Pathogenesis, Presentation and Management of HHS

Ismat Abdelrhman Alborhan Mohammed
Ismat Abdelrhman Alborhan Mohammed Cardiff University

Research Journals